Patterns of hepatitis C viremia in patients receiving hemodialysis

American Journal of Gastroenterology

Volumn 92, Issue 1, 1997, Pages 73-78

  Umlauft, Florian ^a,b   Gruenewald, Kurt ^a   Weiss, Guenter ^a   Kessler, Harald ^c   Urbanek, Martina ^a   Haun, Margot ^a   Santner, Brigitte ^c   Koenig, Paul ^a   Keeffe, Emmet B ^b,d  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GRAZ   (Austria)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HUMAN; MALE; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIREMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RENAL DIALYSIS; RNA, VIRAL; VIREMIA;

EID: 0031013164     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Weiner AJ, Kuo G, Bradley DW, et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 1990;335:1-3.
2. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
3. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
4. Weiner AJ, Truett MA, Rosenblatt J, et al. HCV testing in a low-risk population. Lancet 1990;336:695.
5. Lau JY, Mizokami M, Ohno T, et al. Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. Lancet 1993;342:1208-9.
6. Silva M, Kuhns M, Laverne J, et al. Long-term remission of chronic hepatitis C after interferon (IFN) therapy: Virologie, histologic and biochemical features. Gastroenterology 1992;102:A888 (abstract).
7. Okamoto H, Okada S, Sugiyama Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990; 60:215-22.
8. Garson JA, Tuke PW, Makris M, et al. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates. Lancet 1990;336:1022-5.
9. Shindo M, Di Bisceglie AM, Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon. Hepatology 1992;15:1013-6.
10. Druwe PM, Michielsen PP, Ramon AM, et al. Hepatitis C and nephrology. Nephrol Dial Transplant 1994;9:230-7.
11. Huang CS, Ho MS, Yang CS, et al. Hepatitis C markers in hemodialysis patients. J Clin Microbiol 1993;31:1764-9.
12. Roth D. The significance of hepatitis C virus infection in the care of patients with renal disease. In: Epstein M, ed. The kidney in liver disease, 4th ed. Philadelphia: Hanley & Belfus, 1996: 151-66.
13. Alter HJ. Descartes before the horse: I clone, therefore I am. The hepatitis C virus in current perspective. Ann Intern Med 1991;115: 644-9.
14. Chan TM, Lok AS, Cheng IK, et al. Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993;17:5-8.
15. Bouchardeau F, Chauveau P, Le Marrec N, et al. Detection of hepatitis C virus by polymerase chain reaction in haemodialysed patients in relationship to anti-HCV status. Res Virol 1993;144:233-42.
16. Pol S, Romeo R, Zins B, et al. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: Significance and therapeutic implications. Kidney Int 1993;44:1097-100.
17. Chan TM, Lok AS, Cheng IK, et al. A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 1993;104:862-8.
18. Caramelo C, Ortiz A, Aguilera B, et al. Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis 1993;22:822-8.
19. al Meshari K, al Ahdal M, Alfurayh O, et al. New insights into hepatitis C virus infection in hemodialysis patients: The implications. Am J Kidney Dis 1995;25:572-8.
20. McCruden EA, Welch S, Batchelor B, et al. Hepatitis C virus infection detected by antibody tests and the polymerase chain reaction as a cause of liver dysfunction in renal transplant recipients. J Med Virol 1994; 42:158-63.
21. Chan TM, Wu PC, Lok AS, et al. Clinicopathological features of hepatitis C virus antibody negative fatal chronic hepatitis C after renal transplantation. Nephron 1995;71:213-7.
22. Allander T, Medin C, Jacobson SH, et al. Hepatitis C transmission in a hemodialysis unit: Molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994;43:415-9.
23. Koenig P, Vogel W, Umlauft F, et al. Interferon treatment for chronic hepatitis C virus infection in uremic patients. Kidney Int 1994;45: 1507-9.
24. Hagiwara H, Hayashi N, Mita E, et al. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha. Hepatology 1992;15:37-41.
25. Iino S, Hino K, Kuroki T, et al. Treatment of chronic hepatitis C with high-dose interferon alpha-2b: A multicenter study. Dig Dis Sci 1993; 38:612-8.
26. Pol S, Thiers V, Carnot F, et al. Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients. Kidney Int 1995;47:1412-8.
27. Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alpha: A multicenter randomized controlled trial. N Engl J Med 1989;321:1501-6.
28. Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon alfa therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989;321:1506-10.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
30. Ulrich PP, Romeo JM, Daniel LJ, et al. An improved method for the detection of hepatitis C virus RNA in plasma utilizing heminested primers and internal control RNA. PCR Methods Appl 1993;2:241-9.
31. Young KK, Resnick RM, Myers TW. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol 1993;31:882-6.
32. Stuyver L, Rossau R, Wyseur A, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993;1093-102.
33. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339:237-8.
34. Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994;19: 1321-4.
35. Garson JA. The polymerase chain reaction and hepatitis C virus diagnosis. FEMS Microbiol Rev 1994;14:229-39.
36. Niu MT, Coleman PJ, Alter MJ. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members. Am J Kidney Dis 1993;22:568-73.
37. Gretch D, Corey L, Wilson J, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: High-titer viremia correlates with advanced stage of disease. J Infect Dis 1994;169:1219-25.
38. Hino K, Sainokami S, Shimoda K, et al. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994;42:299-305.
39. Hayashi J, Ohmiya M, Kishihara Y, et al. A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C. Am J Gastroenterol 1994;89:2151-6.
40. Hagiwara H, Hayashi N, Mita E, et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 1993;104:877-83.
41. Naito M, Hayash N, Hagiwara H, et al. Serial quantitative analysis of serum hepatitis C virus RNA level in patients with acute and chronic hepatitis C. J Hepatol 1994;20:755-9.
42. Eyster ME, Fried MW, Di Bisceglie AM, et al. Increasing hepatitis C virus RNA levels in hemophiliacs: Relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood 1994;84:1020-3.
43. Chazouilleres O, Kim M, Combs C, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994;106:994-9.
44. DuBois DB, Gretch D, dela Rosa C, et al. Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: Gender-related differences in viral load. Am J Kidney Dis 1994;24:795-801.
45. Yamada M, Kakumu S, Yoshioka K, et al. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci 1994;39:234-9.
46. McOmish F, Yap PL, Dow BC, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey. J Clin Microbiol 1994;32:884-92.
47. Dusheiko G, Schmilovitz-Weiss H, Brown D, et al. Hepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease. Hepatology 1994;19:13-8.
48. Mahaney K, Tedeschi V, Maertens G, et al. Genotypic analysis of hepatitis C virus in American patients. Hepatology 1994;20:1405-11.